| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.8B | $0.5B | $0.5B | $0.5B | $0.5B | $0.1B | $0.2B | $0.2B |
| EPS (Basic) | $7.90 | $7.01 | $6.50 | $6.65 | $6.76 | $2.20 | $5.40 | $4.90 |
| EPS (Diluted) | $7.87 | $6.97 | $6.46 | $6.60 | $6.71 | $2.19 | $5.36 | $4.86 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $67.2B | $46.4B | $44.9B | $43.9B | $42.0B | $37.8B | $15.9B | $14.7B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | — | — |
| Total Liabilities | $58.1B | $40.5B | $39.4B | $38.8B | $37.2B | $33.1B | $13.5B | $12.3B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $9.1B | $5.9B | $5.5B | $5.1B | $4.8B | $4.6B | $2.4B | $2.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.5B | $0.5B | $1.7B | $0.5B | $0.5B | $0.2B | $0.3B |
| Investing Cash Flow | $0.0B | $-0.9B | $-1.4B | $-4.9B | $-2.3B | $1.2B | $-0.8B | $-0.3B |
| Capital Expenditures | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $1.5B | $0.8B | $0.6B | $-2.3B | $4.0B | $2.2B | $0.9B | $0.0B |